CN115109769B - 一种l-苏氨酸醛缩酶突变体以及在l-丝氨酸合成中的应用 - Google Patents
一种l-苏氨酸醛缩酶突变体以及在l-丝氨酸合成中的应用 Download PDFInfo
- Publication number
- CN115109769B CN115109769B CN202210550936.6A CN202210550936A CN115109769B CN 115109769 B CN115109769 B CN 115109769B CN 202210550936 A CN202210550936 A CN 202210550936A CN 115109769 B CN115109769 B CN 115109769B
- Authority
- CN
- China
- Prior art keywords
- threonine aldolase
- ala
- threonine
- mutant
- aldolase mutant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 title claims abstract description 96
- 108030001992 L-threonine aldolases Proteins 0.000 title claims abstract description 73
- 229960001153 serine Drugs 0.000 title claims abstract description 50
- 230000015572 biosynthetic process Effects 0.000 title abstract description 16
- 238000003786 synthesis reaction Methods 0.000 title abstract description 15
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims abstract description 82
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims abstract description 60
- 239000004471 Glycine Substances 0.000 claims abstract description 30
- 102000004190 Enzymes Human genes 0.000 claims abstract description 25
- 108090000790 Enzymes Proteins 0.000 claims abstract description 25
- 238000003259 recombinant expression Methods 0.000 claims abstract description 21
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims abstract description 14
- 239000004473 Threonine Substances 0.000 claims abstract description 12
- 229960002898 threonine Drugs 0.000 claims abstract description 12
- 230000003197 catalytic effect Effects 0.000 claims abstract description 9
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000000758 substrate Substances 0.000 claims abstract description 8
- 239000013604 expression vector Substances 0.000 claims abstract description 6
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims abstract description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 238000005882 aldol condensation reaction Methods 0.000 claims description 10
- 239000003054 catalyst Substances 0.000 claims description 10
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 claims description 10
- 150000001413 amino acids Chemical group 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 8
- 230000001580 bacterial effect Effects 0.000 claims description 7
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 claims description 7
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 claims description 7
- 239000005515 coenzyme Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 229960001327 pyridoxal phosphate Drugs 0.000 claims description 3
- 230000035484 reaction time Effects 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 26
- 238000000034 method Methods 0.000 abstract description 16
- 239000011942 biocatalyst Substances 0.000 abstract description 2
- 230000003287 optical effect Effects 0.000 abstract description 2
- 108700026220 vif Genes Proteins 0.000 abstract description 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 abstract 1
- 102000002667 Glycine hydroxymethyltransferase Human genes 0.000 description 9
- 108010043428 Glycine hydroxymethyltransferase Proteins 0.000 description 9
- 241000589158 Agrobacterium Species 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- KIPIKSXPPLABPN-CIUDSAMLSA-N Pro-Glu-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1 KIPIKSXPPLABPN-CIUDSAMLSA-N 0.000 description 6
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 4
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 4
- AYFVYJQAPQTCCC-HRFVKAFMSA-N L-allothreonine Chemical compound C[C@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-HRFVKAFMSA-N 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- AAQGRPOPTAUUBM-ZLUOBGJFSA-N Ala-Ala-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O AAQGRPOPTAUUBM-ZLUOBGJFSA-N 0.000 description 3
- BUANFPRKJKJSRR-ACZMJKKPSA-N Ala-Ala-Gln Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](C)C(=O)N[C@H](C([O-])=O)CCC(N)=O BUANFPRKJKJSRR-ACZMJKKPSA-N 0.000 description 3
- UCIYCBSJBQGDGM-LPEHRKFASA-N Ala-Arg-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N UCIYCBSJBQGDGM-LPEHRKFASA-N 0.000 description 3
- YAXNATKKPOWVCP-ZLUOBGJFSA-N Ala-Asn-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O YAXNATKKPOWVCP-ZLUOBGJFSA-N 0.000 description 3
- PXKLCFFSVLKOJM-ACZMJKKPSA-N Ala-Asn-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PXKLCFFSVLKOJM-ACZMJKKPSA-N 0.000 description 3
- FUSPCLTUKXQREV-ACZMJKKPSA-N Ala-Glu-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O FUSPCLTUKXQREV-ACZMJKKPSA-N 0.000 description 3
- UHMQKOBNPRAZGB-CIUDSAMLSA-N Ala-Glu-Met Chemical compound C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)O)N UHMQKOBNPRAZGB-CIUDSAMLSA-N 0.000 description 3
- BTBUEVAGZCKULD-XPUUQOCRSA-N Ala-Gly-His Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CN=CN1 BTBUEVAGZCKULD-XPUUQOCRSA-N 0.000 description 3
- QHASENCZLDHBGX-ONGXEEELSA-N Ala-Gly-Phe Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QHASENCZLDHBGX-ONGXEEELSA-N 0.000 description 3
- LXAARTARZJJCMB-CIQUZCHMSA-N Ala-Ile-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LXAARTARZJJCMB-CIQUZCHMSA-N 0.000 description 3
- MNZHHDPWDWQJCQ-YUMQZZPRSA-N Ala-Leu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O MNZHHDPWDWQJCQ-YUMQZZPRSA-N 0.000 description 3
- BLTRAARCJYVJKV-QEJZJMRPSA-N Ala-Lys-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(O)=O BLTRAARCJYVJKV-QEJZJMRPSA-N 0.000 description 3
- RMAWDDRDTRSZIR-ZLUOBGJFSA-N Ala-Ser-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RMAWDDRDTRSZIR-ZLUOBGJFSA-N 0.000 description 3
- DYXOFPBJBAHWFY-JBDRJPRFSA-N Ala-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N DYXOFPBJBAHWFY-JBDRJPRFSA-N 0.000 description 3
- LSMDIAAALJJLRO-XQXXSGGOSA-N Ala-Thr-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O LSMDIAAALJJLRO-XQXXSGGOSA-N 0.000 description 3
- PGNNQOJOEGFAOR-KWQFWETISA-N Ala-Tyr-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=C(O)C=C1 PGNNQOJOEGFAOR-KWQFWETISA-N 0.000 description 3
- YJHKTAMKPGFJCT-NRPADANISA-N Ala-Val-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O YJHKTAMKPGFJCT-NRPADANISA-N 0.000 description 3
- DHONNEYAZPNGSG-UBHSHLNASA-N Ala-Val-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 DHONNEYAZPNGSG-UBHSHLNASA-N 0.000 description 3
- RRGPUNYIPJXJBU-GUBZILKMSA-N Arg-Asp-Met Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O RRGPUNYIPJXJBU-GUBZILKMSA-N 0.000 description 3
- TTXYKSADPSNOIF-IHRRRGAJSA-N Arg-Asp-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O TTXYKSADPSNOIF-IHRRRGAJSA-N 0.000 description 3
- GOWZVQXTHUCNSQ-NHCYSSNCSA-N Arg-Glu-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O GOWZVQXTHUCNSQ-NHCYSSNCSA-N 0.000 description 3
- UBCPNBUIQNMDNH-NAKRPEOUSA-N Arg-Ile-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O UBCPNBUIQNMDNH-NAKRPEOUSA-N 0.000 description 3
- LVMUGODRNHFGRA-AVGNSLFASA-N Arg-Leu-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O LVMUGODRNHFGRA-AVGNSLFASA-N 0.000 description 3
- ZEBDYGZVMMKZNB-SRVKXCTJSA-N Arg-Met-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCN=C(N)N)N ZEBDYGZVMMKZNB-SRVKXCTJSA-N 0.000 description 3
- CZUHPNLXLWMYMG-UBHSHLNASA-N Arg-Phe-Ala Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 CZUHPNLXLWMYMG-UBHSHLNASA-N 0.000 description 3
- YTMKMRSYXHBGER-IHRRRGAJSA-N Arg-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N YTMKMRSYXHBGER-IHRRRGAJSA-N 0.000 description 3
- NIELFHOLFTUZME-HJWJTTGWSA-N Arg-Phe-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NIELFHOLFTUZME-HJWJTTGWSA-N 0.000 description 3
- ASQKVGRCKOFKIU-KZVJFYERSA-N Arg-Thr-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O ASQKVGRCKOFKIU-KZVJFYERSA-N 0.000 description 3
- QCTOLCVIGRLMQS-HRCADAONSA-N Arg-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O QCTOLCVIGRLMQS-HRCADAONSA-N 0.000 description 3
- IPPFAOCLQSGHJV-WFBYXXMGSA-N Asn-Trp-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(O)=O IPPFAOCLQSGHJV-WFBYXXMGSA-N 0.000 description 3
- SBHUBSDEZQFJHJ-CIUDSAMLSA-N Asp-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O SBHUBSDEZQFJHJ-CIUDSAMLSA-N 0.000 description 3
- DTNUIAJCPRMNBT-WHFBIAKZSA-N Asp-Gly-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C)C(O)=O DTNUIAJCPRMNBT-WHFBIAKZSA-N 0.000 description 3
- UMHUHHJMEXNSIV-CIUDSAMLSA-N Asp-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UMHUHHJMEXNSIV-CIUDSAMLSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- CVLIHKBUPSFRQP-WHFBIAKZSA-N Cys-Gly-Ala Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(O)=O CVLIHKBUPSFRQP-WHFBIAKZSA-N 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- CYTSBCIIEHUPDU-ACZMJKKPSA-N Gln-Asp-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O CYTSBCIIEHUPDU-ACZMJKKPSA-N 0.000 description 3
- SHAUZYVSXAMYAZ-JYJNAYRXSA-N Gln-Leu-Phe Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCC(=O)N)N SHAUZYVSXAMYAZ-JYJNAYRXSA-N 0.000 description 3
- KKCUFHUTMKQQCF-SRVKXCTJSA-N Glu-Arg-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O KKCUFHUTMKQQCF-SRVKXCTJSA-N 0.000 description 3
- XXCDTYBVGMPIOA-FXQIFTODSA-N Glu-Asp-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XXCDTYBVGMPIOA-FXQIFTODSA-N 0.000 description 3
- WTMZXOPHTIVFCP-QEWYBTABSA-N Glu-Ile-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WTMZXOPHTIVFCP-QEWYBTABSA-N 0.000 description 3
- VIPDPMHGICREIS-GVXVVHGQSA-N Glu-Val-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O VIPDPMHGICREIS-GVXVVHGQSA-N 0.000 description 3
- FKJQNJCQTKUBCD-XPUUQOCRSA-N Gly-Ala-His Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O FKJQNJCQTKUBCD-XPUUQOCRSA-N 0.000 description 3
- GHHAMXVMWXMGSV-STQMWFEESA-N Gly-Cys-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CS)NC(=O)CN)C(O)=O)=CNC2=C1 GHHAMXVMWXMGSV-STQMWFEESA-N 0.000 description 3
- XPJBQTCXPJNIFE-ZETCQYMHSA-N Gly-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)CN XPJBQTCXPJNIFE-ZETCQYMHSA-N 0.000 description 3
- UUYBFNKHOCJCHT-VHSXEESVSA-N Gly-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN UUYBFNKHOCJCHT-VHSXEESVSA-N 0.000 description 3
- LOEANKRDMMVOGZ-YUMQZZPRSA-N Gly-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(O)=O)C(O)=O LOEANKRDMMVOGZ-YUMQZZPRSA-N 0.000 description 3
- PCPOYRCAHPJXII-UWVGGRQHSA-N Gly-Lys-Met Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(O)=O PCPOYRCAHPJXII-UWVGGRQHSA-N 0.000 description 3
- WDXLKVQATNEAJQ-BQBZGAKWSA-N Gly-Pro-Asp Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O WDXLKVQATNEAJQ-BQBZGAKWSA-N 0.000 description 3
- DNVDEMWIYLVIQU-RCOVLWMOSA-N Gly-Val-Asp Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O DNVDEMWIYLVIQU-RCOVLWMOSA-N 0.000 description 3
- JIUYRPFQJJRSJB-QWRGUYRKSA-N His-His-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)NCC(O)=O)C1=CN=CN1 JIUYRPFQJJRSJB-QWRGUYRKSA-N 0.000 description 3
- QLBXWYXMLHAREM-PYJNHQTQSA-N His-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC1=CN=CN1)N QLBXWYXMLHAREM-PYJNHQTQSA-N 0.000 description 3
- UNDGQKWQNSTPPW-CYDGBPFRSA-N Ile-Arg-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCSC)C(=O)O)N UNDGQKWQNSTPPW-CYDGBPFRSA-N 0.000 description 3
- DFJJAVZIHDFOGQ-MNXVOIDGSA-N Ile-Glu-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N DFJJAVZIHDFOGQ-MNXVOIDGSA-N 0.000 description 3
- WIYDLTIBHZSPKY-HJWJTTGWSA-N Ile-Val-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 WIYDLTIBHZSPKY-HJWJTTGWSA-N 0.000 description 3
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 3
- HXWALXSAVBLTPK-NUTKFTJISA-N Leu-Ala-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(C)C)N HXWALXSAVBLTPK-NUTKFTJISA-N 0.000 description 3
- YOZCKMXHBYKOMQ-IHRRRGAJSA-N Leu-Arg-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N YOZCKMXHBYKOMQ-IHRRRGAJSA-N 0.000 description 3
- OGUUKPXUTHOIAV-SDDRHHMPSA-N Leu-Glu-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N OGUUKPXUTHOIAV-SDDRHHMPSA-N 0.000 description 3
- MPSBSKHOWJQHBS-IHRRRGAJSA-N Leu-His-Met Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCSC)C(=O)O)N MPSBSKHOWJQHBS-IHRRRGAJSA-N 0.000 description 3
- HGFGEMSVBMCFKK-MNXVOIDGSA-N Leu-Ile-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O HGFGEMSVBMCFKK-MNXVOIDGSA-N 0.000 description 3
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 3
- ZXEUFAVXODIPHC-GUBZILKMSA-N Lys-Glu-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ZXEUFAVXODIPHC-GUBZILKMSA-N 0.000 description 3
- LMKSBGIUPVRHEH-FXQIFTODSA-N Met-Ala-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(N)=O LMKSBGIUPVRHEH-FXQIFTODSA-N 0.000 description 3
- WNJXJJSGUXAIQU-UFYCRDLUSA-N Met-Phe-Phe Chemical compound C([C@H](NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 WNJXJJSGUXAIQU-UFYCRDLUSA-N 0.000 description 3
- SPSSJSICDYYTQN-HJGDQZAQSA-N Met-Thr-Gln Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(N)=O SPSSJSICDYYTQN-HJGDQZAQSA-N 0.000 description 3
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 3
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 3
- BJEYSVHMGIJORT-NHCYSSNCSA-N Phe-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 BJEYSVHMGIJORT-NHCYSSNCSA-N 0.000 description 3
- BKWJQWJPZMUWEG-LFSVMHDDSA-N Phe-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 BKWJQWJPZMUWEG-LFSVMHDDSA-N 0.000 description 3
- MQVFHOPCKNTHGT-MELADBBJSA-N Phe-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O MQVFHOPCKNTHGT-MELADBBJSA-N 0.000 description 3
- MGBRZXXGQBAULP-DRZSPHRISA-N Phe-Glu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 MGBRZXXGQBAULP-DRZSPHRISA-N 0.000 description 3
- NAXPHWZXEXNDIW-JTQLQIEISA-N Phe-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=CC=C1 NAXPHWZXEXNDIW-JTQLQIEISA-N 0.000 description 3
- CDHURCQGUDNBMA-UBHSHLNASA-N Phe-Val-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 CDHURCQGUDNBMA-UBHSHLNASA-N 0.000 description 3
- OOLOTUZJUBOMAX-GUBZILKMSA-N Pro-Ala-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O OOLOTUZJUBOMAX-GUBZILKMSA-N 0.000 description 3
- HXOLCSYHGRNXJJ-IHRRRGAJSA-N Pro-Asp-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HXOLCSYHGRNXJJ-IHRRRGAJSA-N 0.000 description 3
- HRIXMVRZRGFKNQ-HJGDQZAQSA-N Pro-Thr-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HRIXMVRZRGFKNQ-HJGDQZAQSA-N 0.000 description 3
- FIXILCYTSAUERA-FXQIFTODSA-N Ser-Ala-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FIXILCYTSAUERA-FXQIFTODSA-N 0.000 description 3
- YUSRGTQIPCJNHQ-CIUDSAMLSA-N Ser-Arg-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O YUSRGTQIPCJNHQ-CIUDSAMLSA-N 0.000 description 3
- SMIDBHKWSYUBRZ-ACZMJKKPSA-N Ser-Glu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O SMIDBHKWSYUBRZ-ACZMJKKPSA-N 0.000 description 3
- LALNXSXEYFUUDD-GUBZILKMSA-N Ser-Glu-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LALNXSXEYFUUDD-GUBZILKMSA-N 0.000 description 3
- UAJAYRMZGNQILN-BQBZGAKWSA-N Ser-Gly-Met Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O UAJAYRMZGNQILN-BQBZGAKWSA-N 0.000 description 3
- FUMGHWDRRFCKEP-CIUDSAMLSA-N Ser-Leu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O FUMGHWDRRFCKEP-CIUDSAMLSA-N 0.000 description 3
- KCNSGAMPBPYUAI-CIUDSAMLSA-N Ser-Leu-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O KCNSGAMPBPYUAI-CIUDSAMLSA-N 0.000 description 3
- FPCGZYMRFFIYIH-CIUDSAMLSA-N Ser-Lys-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O FPCGZYMRFFIYIH-CIUDSAMLSA-N 0.000 description 3
- RXUOAOOZIWABBW-XGEHTFHBSA-N Ser-Thr-Arg Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N RXUOAOOZIWABBW-XGEHTFHBSA-N 0.000 description 3
- KBBRNEDOYWMIJP-KYNKHSRBSA-N Thr-Gly-Thr Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)O)N)O KBBRNEDOYWMIJP-KYNKHSRBSA-N 0.000 description 3
- UGFSAPWZBROURT-IXOXFDKPSA-N Thr-Phe-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CS)C(=O)O)N)O UGFSAPWZBROURT-IXOXFDKPSA-N 0.000 description 3
- ZESGVALRVJIVLZ-VFCFLDTKSA-N Thr-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@@H]1C(=O)O)N)O ZESGVALRVJIVLZ-VFCFLDTKSA-N 0.000 description 3
- MYNYCUXMIIWUNW-IEGACIPQSA-N Thr-Trp-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCCCN)C(=O)O)N)O MYNYCUXMIIWUNW-IEGACIPQSA-N 0.000 description 3
- UJRIVCPPPMYCNA-HOCLYGCPSA-N Trp-Leu-Gly Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N UJRIVCPPPMYCNA-HOCLYGCPSA-N 0.000 description 3
- FGJWNBBFAUHBEP-IHPCNDPISA-N Tyr-Asp-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N FGJWNBBFAUHBEP-IHPCNDPISA-N 0.000 description 3
- NKUGCYDFQKFVOJ-JYJNAYRXSA-N Tyr-Leu-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NKUGCYDFQKFVOJ-JYJNAYRXSA-N 0.000 description 3
- BTWMICVCQLKKNR-DCAQKATOSA-N Val-Leu-Ser Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C([O-])=O BTWMICVCQLKKNR-DCAQKATOSA-N 0.000 description 3
- OFTXTCGQJXTNQS-XGEHTFHBSA-N Val-Thr-Ser Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)N)O OFTXTCGQJXTNQS-XGEHTFHBSA-N 0.000 description 3
- 108010044940 alanylglutamine Proteins 0.000 description 3
- 108010047495 alanylglycine Proteins 0.000 description 3
- 108010087924 alanylproline Proteins 0.000 description 3
- 108010070783 alanyltyrosine Proteins 0.000 description 3
- 108010038633 aspartylglutamate Proteins 0.000 description 3
- 108010047857 aspartylglycine Proteins 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- -1 compound amino acid Chemical class 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 108010049041 glutamylalanine Proteins 0.000 description 3
- 108010026364 glycyl-glycyl-leucine Proteins 0.000 description 3
- 108010089804 glycyl-threonine Proteins 0.000 description 3
- 108010050848 glycylleucine Proteins 0.000 description 3
- 108010040030 histidinoalanine Proteins 0.000 description 3
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 3
- 108010063431 methionyl-aspartyl-glycine Proteins 0.000 description 3
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 3
- 108010012581 phenylalanylglutamate Proteins 0.000 description 3
- 108010051242 phenylalanylserine Proteins 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 108010004914 prolylarginine Proteins 0.000 description 3
- 108010090894 prolylleucine Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 108010015666 tryptophyl-leucyl-glutamic acid Proteins 0.000 description 3
- 108010084932 tryptophyl-proline Proteins 0.000 description 3
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 150000001299 aldehydes Chemical class 0.000 description 2
- 150000001371 alpha-amino acids Chemical class 0.000 description 2
- 235000008206 alpha-amino acids Nutrition 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000010523 cascade reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 239000012847 fine chemical Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 2
- 235000019799 monosodium phosphate Nutrition 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000007065 protein hydrolysis Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 108010049097 threonine acetaldehyde-lyase Proteins 0.000 description 2
- MSTNYGQPCMXVAQ-RYUDHWBXSA-N (6S)-5,6,7,8-tetrahydrofolic acid Chemical compound C([C@H]1CNC=2N=C(NC(=O)C=2N1)N)NC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 MSTNYGQPCMXVAQ-RYUDHWBXSA-N 0.000 description 1
- AGNGYMCLFWQVGX-AGFFZDDWSA-N (e)-1-[(2s)-2-amino-2-carboxyethoxy]-2-diazonioethenolate Chemical compound OC(=O)[C@@H](N)CO\C([O-])=C\[N+]#N AGNGYMCLFWQVGX-AGFFZDDWSA-N 0.000 description 1
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 description 1
- 206010000830 Acute leukaemia Diseases 0.000 description 1
- 108010031025 Alanine Dehydrogenase Proteins 0.000 description 1
- 108030000948 Alditol oxidases Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- DYDCUQKUCUHJBH-UWTATZPHSA-N D-Cycloserine Chemical compound N[C@@H]1CONC1=O DYDCUQKUCUHJBH-UWTATZPHSA-N 0.000 description 1
- DYDCUQKUCUHJBH-UHFFFAOYSA-N D-Cycloserine Natural products NC1CONC1=O DYDCUQKUCUHJBH-UHFFFAOYSA-N 0.000 description 1
- 108010001539 D-lactate dehydrogenase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102100023319 Dihydrolipoyl dehydrogenase, mitochondrial Human genes 0.000 description 1
- 108090000698 Formate Dehydrogenases Proteins 0.000 description 1
- BXICSAQLIHFDDL-YUMQZZPRSA-N Gly-Lys-Asn Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BXICSAQLIHFDDL-YUMQZZPRSA-N 0.000 description 1
- 108010020056 Hydrogenase Proteins 0.000 description 1
- 241000588915 Klebsiella aerogenes Species 0.000 description 1
- 101710191971 Low specificity L-threonine aldolase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000018120 Recombinases Human genes 0.000 description 1
- 108010091086 Recombinases Proteins 0.000 description 1
- 101150078140 SHMT gene Proteins 0.000 description 1
- HDBOEVPDIDDEPC-CIUDSAMLSA-N Ser-Lys-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O HDBOEVPDIDDEPC-CIUDSAMLSA-N 0.000 description 1
- 241001518135 Shewanella algae Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- BDGBHYCAZJPLHX-HJGDQZAQSA-N Thr-Lys-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O BDGBHYCAZJPLHX-HJGDQZAQSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000037354 amino acid metabolism Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229950011321 azaserine Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229960003077 cycloserine Drugs 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000009510 drug design Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000005460 tetrahydrofolate Substances 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/06—Alanine; Leucine; Isoleucine; Serine; Homoserine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y401/00—Carbon-carbon lyases (4.1)
- C12Y401/02—Aldehyde-lyases (4.1.2)
- C12Y401/02005—L-Threonine aldolase (4.1.2.5)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/584—Recycling of catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明公开了一种L‑苏氨酸醛缩酶突变体及其编码基因、重组表达载体、重组表达转化体以及在L‑丝氨酸合成中的应用。L‑苏氨酸醛缩酶突变体包括:以SEQ ID No.2所示野生型的L‑苏氨酸醛缩酶为模板,第202位苏氨酸替换为丝氨酸或甘氨酸所形成的L‑苏氨酸醛缩酶突变体T202S、T202G。该L‑苏氨酸醛缩酶突变体与其他生物催化剂相比,可以在目前已知最高浓度的醛类底物下发挥催化活性,并且转化率>99%。同时本发明所提供的L‑苏氨酸醛缩酶催化甲醛和甘氨酸生成L‑丝氨酸的方法,具有原子经济性高、产品光学纯度高、反应条件温和、环境友好、产品后处理简单等优势,在L‑丝氨酸的合成中表现出良好的应用前景。
Description
技术领域
本发明涉及生物工程技术领域,更具体地涉及一种L-苏氨酸醛缩酶突变体以及在L-丝氨酸合成中的应用。
背景技术
L-丝氨酸又名L-2-氨基-3-羟基丙酸,其在生物体内处于氨基酸代谢的中间位置,具有许多重要的生理作用。其可以用来合成多种氨基酸、核酸碱基以及磷脂等物质。目前普遍应用于医药、食品以及化妆品等领域,例如,在医药领域中,L-丝氨酸可以用来配置复方氨基酸输液以及作为营养增补剂,同时它也在稳定肝脏血糖浓度方面起着重要作用。L-丝氨酸常常添加在高级化妆品中以提高化妆品的保湿性,其还具有一定的抗菌和表面活性剂的作用。此外,L-丝氨酸可以和糖类在高温下发生美拉德反应使食物产生特殊的香味。同时其多种衍生物也具有很多重要的功能,例如环丝氨酸可以用来治疗结核病,偶氮丝氨酸可以用来治疗肿瘤以及急性白血病和柯杰金氏病。
L-丝氨酸的生产方法有多种,包括化学合成法、蛋白质水解法、发酵法以及生物酶法。化学合成法的缺点主要是反应步骤繁琐,还需要进行多步纯化才能获得光学纯的手性L-丝氨酸。蛋白质水解法过程较为繁琐,水解终点难以准确判断,L-丝氨酸损失率较高,同时对环境污染严重。当下L-丝氨酸的生产方法主要是前体发酵法,但此方法后续分离困难从而导致成本较高,同时对生产设备也有较高的要求。与以上三种方法相比较而言,生物酶法具有反应条件温和、立体选择性高和环境友好等优点,已广泛用于医药中间体、精细化学品等手性化学品的工业生产中。目前,L-丝氨酸生物合成涉及到的酶主要为丝氨酸羟甲基转移酶(SHMT),它催化过程相对复杂,不仅需要PLP作为辅酶,还需要四氢叶酸的存在才能催化反应生成L-丝氨酸,导致后续分离纯化成本的增加。因此,仍需要寻求一个能够相对简单高效生产L-丝氨酸的方法。
魏江筛选出了一种新的利用甲醇的海洋细菌菌株Shewanella algae,显示出高SHMT活性。将该SHMT基因成功克隆至大肠杆菌(DE3)中进行表达,并对其酶学性质和催化活性进行了研究,发现该酶可以转化产生77.76mM的L-丝氨酸。Hsiao H Y采用Klebsiellaaerogenes GX1705(pGX 2236)重组菌株表达的SHMT的粗提物形式,研究了甘氨酸和甲醛(HCHO)生产L-丝氨酸的过程。通过仔细平衡甲醛进料速率与酶促生物转化速率,在保持甲醛浓度处于较低水平的条件下,丝氨酸总产率可以达到5.2g/L/h。最近,山东大学的马翠卿团队设计了一种体外酶级联反应,用于从甘油生产L-丝氨酸,涉及到的酶包括醛糖醇氧化酶、D-乳酸脱氢酶、L-丙氨酸脱氢酶、甲酸脱氢酶以及过氧化氢酶。在优化各个酶的投量后,以18.51mM甘油制备了17.58mM L-丝氨酸。
苏氨酸醛缩酶(TA)是一种依赖5′磷酸吡哆醛(PLP)的酶,其可以在甘氨酸的次级合成途径中催化L-苏氨酸和L-别-苏氨酸生成甘氨酸和乙醛。苏氨酸醛缩酶的逆反应过程中涉及不对称碳-碳键的形成,在体外,其可以催化α-氨基酸和不同类型的醛生成β-羟基-α-氨基酸,产生两个新的相邻立体中心。β-羟基-α-氨基酸是许多复杂天然产物和药物的重要组成部分,这使得该酶在医药和精细化工等领域具有巨大的应用潜力。根据其对苏氨酸α-碳的立体特异性,可分为L--苏氨酸醛缩酶(L-TA)和D-苏氨酸醛缩酶(D-TA)。L-苏氨酸醛缩酶在α-碳上表现出很高的立体特异性,因此严格来说只生成L-型产物,其可以催化L-苏氨酸和非天然的L-β-羟基-α氨基酸的可逆裂解生成甘氨酸和相应的醛类。L-TA又可分为三类:(1)特异性裂解L-别-苏氨酸的L-alloTA(EC4.1.2.49);(2)特异性裂解L-苏氨酸的L-TA(EC4.1.2.5);(3)对L-苏氨酸和L-别-苏氨酸均具有裂解活性的低特异性L-TA(EC4.1.2.48)。
目前为止,研究较多的生产L-丝氨酸的酶是丝氨酸羟甲基转移酶,其反应过程复杂,且大部分是应用于发酵法来生产L-丝氨酸。此外,其他报道的生产L-丝氨酸的酶级联反应涉及到多个酶,此过程较为复杂,且产量较低。因此,仍需挖掘一个能够相对简单高效催化L-丝氨酸合成的酶。
发明内容
本发明的目的是提供一种L-苏氨酸醛缩酶突变体以及在L-丝氨酸合成中的应用,从而解决现有L-丝氨酸的产量尚不能完全满足市场需求,且其现在主要生产方法为前体发酵法,其存在后续分离困难,纯化成本较高,对生产设备也有较高要求的问题。
为了解决上述问题,本发明采用以下技术方案:
根据本发明的第一方面,提供一种L-苏氨酸醛缩酶突变体,所述L-苏氨酸醛缩酶突变体包括:以SEQ ID No.2所示野生型的L-苏氨酸醛缩酶为模板,第202位苏氨酸替换为丝氨酸所形成的L-苏氨酸醛缩酶突变体T202S,其氨基酸序列如SEQ ID No.3所示;以及以SEQ ID No.2所示野生型的L-苏氨酸醛缩酶为模板,第202位苏氨酸替换为甘氨酸所形成的L-苏氨酸醛缩酶突变体T202G,其氨基酸序列如SEQ ID No.4所示。
所述野生型的L-苏氨酸醛缩酶是一种来自于Agrobacterium菌株的L-苏氨酸醛缩酶,其NCBI登录号为WP_006313436.1。
根据本发明的第二方面,提供一种编码如前面所述的L-苏氨酸醛缩酶突变体的编码基因。
根据本发明的第三方面,提供一种包含如前面所述的L-苏氨酸醛缩酶突变体的编码基因的重组表达载体。
根据本发明的第四方面,提供一种包含如前面所述的L-苏氨酸醛缩酶突变体的编码基因的重组表达转化体。可通过将构建的重组表达载体转化至宿主细胞来制备重组表达转化体。所述宿主细胞为本领域的各种常规宿主细胞,只要所述的重组表达载体能够稳定地自行复制并能通过诱导剂诱导后有效表达目标蛋白质即可。本发明首选大肠杆菌作为宿主细胞,优选大肠杆菌E.coli BL21(DE3)用于高效表达本发明所述的L-苏氨酸醛缩酶突变体。
根据本发明的第五方面,提供一种L-苏氨酸醛缩酶突变体催化剂,所述的重组L-苏氨酸醛缩酶突变体催化剂是以下形式中的任意一种:1)培养如前面所述的重组表达转化体,分离含有所述L-苏氨酸醛缩酶突变体的转化体细胞;2)培养如前面所述的重组表达转化体,分离含有所述L-苏氨酸醛缩酶突变体的粗酶液;3)培养如前面所述的重组表达转化体,分离含有所述L-苏氨酸醛缩酶突变体的粗酶液,干燥所制备的粗酶粉或纯化所制备的纯酶;4)培养如前面所述的重组表达转化体,分离含有所述L-苏氨酸醛缩酶突变体的转化体细胞,之后冷冻干燥得到的冻干菌粉。
根据本发明的第六方面,提供一种利用如前面所述的L-苏氨酸醛缩酶突变体或如前面所述的L-苏氨酸醛缩酶突变体催化剂在催化甲醛和甘氨酸生成L-丝氨酸中的应用。
使用所述L-苏氨酸醛缩酶突变体或所述L-苏氨酸醛缩酶突变体催化剂,催化甲醛和甘氨酸的羟醛缩合反应,获得L-丝氨酸。
优选地,所述L-苏氨酸醛缩酶突变体催化甲醛和甘氨酸的羟醛缩合反应在辅酶PLP的存在下进行。
L-苏氨酸醛缩酶突变体催化剂可以催化甲醛和甘氨酸发生羟醛缩合生成L-丝氨酸。在所述应用中,底物甲醛的浓度为10~300mM,底物甘氨酸的浓度为100~1500mM,所述L-苏氨酸醛缩酶的用量为冻干菌粉5~30g/L,辅酶磷酸吡哆醛的添加量为10~200μM。反应过程中所需的磷酸氢二钠/磷酸二氢钠缓冲液(但不限于磷酸氢二钠/磷酸二氢钠缓冲液)为本领域常规缓冲液,其浓度为50~200mM。
所述反应在pH 6~10,例如pH 7~9或pH8~9的条件下进行。所述反应是在振荡或搅拌条件下进行。所述反应的温度为20~50℃,优选30℃。所述反应的时间以底物完全转化或反应自行终止的时间为准,优选反应时间小于24h。
本发明的关键发明点在于,通过对酶进行半理性设计,提供一种在较高甲醛浓度下具有优良催化活性的L-苏氨酸醛缩酶突变体,解决了在高浓度甲醛下活性下降的问题,奠定其在L-丝氨酸合成中的应用。
具体而言,本发明涉及一种农杆菌属(Agrobacterium)来源的L-苏氨酸醛缩酶突变体及其基因、含有该基因的重组表达载体和重组表达转化体,以及利用该重组L-苏氨酸醛缩酶或重组表达转化体催化甲醛和甘氨酸发生羟醛缩合反应生成L-丝氨酸的应用,该生物催化剂能够在高浓度甲醛下表现出优良的催化性能,在L-丝氨酸的合成中显示出良好的应用前景。
与现有技术相比,本发明的有益效果如下:
本发明提供了一种催化性能更好的L-苏氨酸醛缩酶的突变体,可高效催化甲醛和甘氨酸的羟醛缩合反应制备L-丝氨酸。野生型L-苏氨酸醛缩酶催化甲醛和甘氨酸合成L-丝氨酸时,会受到高浓度甲醛的影响导致催化性能下降,然而,本发明提供的L-丝氨酸醛缩酶突变体具有催化活性高、可耐受底物浓度高、无其它副产物的优点,能够催化浓度高达200mM甲醛的底物转化,实现99%以上的转化率,且无副产物生成。同时,本发明所提供的L-苏氨酸醛缩酶催化甲醛和甘氨酸生成L-丝氨酸的方法,与其他制备方法相比,催化过程简单,且反应无副产物产生,后续分离简单,因此具有原子经济性高、产品光学纯度高、反应条件温和、环境友好、产品后处理简单等优势,在L-丝氨酸的合成中表现出良好的应用前景。
附图说明
图1为L-苏氨酸醛缩酶催化甲醛和甘氨酸生产L-丝氨酸的反应式。
具体实施方式
以下结合具体实施例,对本发明做进一步说明。应理解,以下实施例仅用于说明本发明而非用于限制本发明的范围。
材料和方法
基因工程所用材料和试剂:E.coli BL21(DE3)、质粒pET-28a(+)来自本实验室保藏。质粒提取试剂盒、DNA纯化回收试剂盒购自TOROIVD科技有限公司;SDS-PAGE凝胶快速制备试剂盒购自上海雅酶生物科技;DNA marker购自北京全式金生物技术;以上试剂使用方法参考商品说明书。
引物合成,序列测序工作由北京擎科生物公司(上海)完成。
甘氨酸购自上海泰坦科技,其余均购自于国药集团化学试剂有限公司。
实施例1:菌株构建
将来源于农杆菌属(Agrobacterium)的注释为L-丝氨酸醛缩酶(Ag-LTA)的序列克隆出来,插入表达质粒pET-28a得到pET28a-Ag-LTA。L-苏氨酸醛缩酶Ag-LTA的基因序列如SEQ ID No.1所示。测序验证无误后将pET28a-Ag-LTA转入表达宿主大肠杆菌E.coli BL21(DE3)中用于后续重组酶的表达。
实施例2:突变体构建
以重组质粒Ag-LTA为母本,对拟突变位点分别设计引物,上下游引物序列如表1中所示。PCR体系:10μL的DNA聚合酶P515,正反向引物各1μL,1μL的模板,7μL的双蒸水,总体系为20μL。PCR程序:首先95℃预变形5min;之后按下列程序循环30次:95℃变性30s,Tm+5℃退火30s,72℃延伸5.5min;72℃终延伸3min,4℃维持。
表1 Ag-LTA突变体构建所使用的引物
通过突变获得系列L-苏氨酸醛缩酶Ag-LTA的突变体,包括:
1)将如SEQ ID No.2所示氨基酸序列的第202位苏氨酸氨酸替换为丝氨酸所形成的衍生蛋白质,其氨基酸序列如SEQ ID No.3所示,命名为T202S;
2)将如SEQ ID No.2所示氨基酸序列的第202位苏氨酸氨酸替换为甘氨酸所形成的衍生蛋白质,其氨基酸序列如SEQ ID No.4所示,命名为T202G。
实施例3:菌株培养
将重组表达转化子接种到装有含有抗性的5mL LB液体培养基的试管中,于37℃恒温摇床过夜培养。之后取500μL过夜培养的菌液加入到装有50mL LB液体培养基(含有抗性的)的250mL的摇瓶中,37℃恒温摇床培养2.5h左右,OD600达到0.6左右。加入终浓度0.1mMIPTG进行诱导,置于20℃恒温摇床诱导表达18-20h。诱导表达结束后,将菌液倒入50mL离心管中,配平后,4℃,8000rpm,离心10min。离心结束后,弃去上清,加入15mL的生理盐水,重悬菌体,配平后,4℃,8000rpm,离心10min。离心结束后,弃去上清,进行空转,当转速达到6000rpm时停止离心,使用移液枪吸去残留上清液体,将收集的菌体保存在-40℃的冰箱中备用。后续将收获的重组细胞加入一定体积的缓冲液进行超声破碎,离心收集上清液,即可获得粗酶液;使用真空冷冻干燥机冷冻干燥,即可得到冻干酶粉。用于催化甲醛和甘氨酸生成L-丝氨酸的反应。
实施例4:Ag-LTA突变体催化甲醛和甘氨酸反应生成L-丝氨酸
重组L-苏氨酸醛缩酶突变体或L-苏氨酸醛缩酶突变体催化剂催化甲醛和甘氨酸缩合反应生成L-丝氨酸原理示意图如图1所示。
在10mL的反应体系中加入100mg野生型/突变体的冻干菌粉、0.2M甲醛、1M甘氨酸以及磷酸钠缓冲液(0.1M pH8.0),反应液置于30℃、转速250rpm条件下反应。反应结束后加入2M盐酸终止反应,离心取上清之后进行DNFB(2,4-二硝基氟苯)衍生进行HPLC分析。L-苏氨酸醛缩酶及突变体催化的甲醛和甘氨酸羟醛缩合反应结果如表2所示,当甲醛浓度为200mM时,Ag-LTA突变体T202S、T202G的转化率均大于99%,远高于野生型。
表2 L-苏氨酸醛缩酶及突变体催化的甲醛和甘氨酸羟醛缩合反应结果
以上所述的,仅为本发明的较佳实施例,并非用以限定本发明的范围,本发明的上述实施例还可以做出各种变化。凡是依据本发明申请的权利要求书及说明书内容所作的简单、等效变化与修饰,皆落入本发明专利的权利要求保护范围。本发明未详尽描述的均为常规技术内容。
SEQUENCE LISTING
<110> 华东理工大学
<120> 一种L-苏氨酸醛缩酶突变体以及在L-丝氨酸合成中的应用
<160> 8
<170> PatentIn version 3.5
<210> 1
<211> 1053
<212> DNA
<213> Agrobacterium
<400> 1
atgttttttg cttcagacaa ttgggctggc gcccatccgg ccgtcaatga acggctgtcg 60
cgggaatcca cgcgttttgc cgccgcttac ggcaccagcg aactcgatct ctccatcgaa 120
aaacgcttca acgaaatctt cgaacgcgaa gtcgcggttt tttttgtcgc caccggcacg 180
gcggccaatt cgctttcgct ggccagcatc gcccgtcccg gcggcctgac cttctgtcat 240
tcggaagcgc atgtgatcga ggacgaatgt ggcgcgccgg atttcttttc aggcatgcgc 300
atggtcgccg tcgaggggcc tgatggcaag atgctgccgg agaacctcat cgagcgcatt 360
gcgcgctatc cgcaggatgc cgtgcaccat gggcgcgccg cagccattac catgacgcag 420
gcgactgaag ccggcaccgt ctatacgctt gatgaaatcg acgctatatc caaaatcgcc 480
aaggaaaacg gcctgccgtt gcatatggat ggcgcgcggt ttgccaatgc acttgccgca 540
ctcggcacga cgccggctga aatgacctgg aaacgcggcg tcgatgtcct gtctttcggc 600
ggcacgaaaa acggctgctg gtgcgcggaa gcgatcgtgt ttttcgatcc ttcgcttgcc 660
cgggacttct ccttcctgcg caagcgtacc gcccagcttt tttcgaaatc gcgtttcatc 720
gccgcgcaat tcgaagccta cctgcaggac gacctgtggc tcggtctcgc cggccacgcc 780
aatgccatgg ccaaccggct gcgcgccggt ttcggctcac tgaacagcgc ccgcctggca 840
tggccgacac aggccaacga ggttttcgcc attctgccca aggcagccgc tgaagcggcg 900
acgcaaaaag gcgcgaagtt ctatgactgg ctggagccgc gcgacatgcc ggaaaatgtc 960
ggcaaggacg aagtactgat ccgcatggtc acgagctttg cgacgaccga agctgatgtg 1020
gacgaattcc tgtcgatctg cgctgccgtc tga 1053
<210> 2
<211> 350
<212> PRT
<213> Agrobacterium
<400> 2
Met Phe Phe Ala Ser Asp Asn Trp Ala Gly Ala His Pro Ala Val Asn
1 5 10 15
Glu Arg Leu Ser Arg Glu Ser Thr Arg Phe Ala Ala Ala Tyr Gly Thr
20 25 30
Ser Glu Leu Asp Leu Ser Ile Glu Lys Arg Phe Asn Glu Ile Phe Glu
35 40 45
Arg Glu Val Ala Val Phe Phe Val Ala Thr Gly Thr Ala Ala Asn Ser
50 55 60
Leu Ser Leu Ala Ser Ile Ala Arg Pro Gly Gly Leu Thr Phe Cys His
65 70 75 80
Ser Glu Ala His Val Ile Glu Asp Glu Cys Gly Ala Pro Asp Phe Phe
85 90 95
Ser Gly Met Arg Met Val Ala Val Glu Gly Pro Asp Gly Lys Met Leu
100 105 110
Pro Glu Asn Leu Ile Glu Arg Ile Ala Arg Tyr Pro Gln Asp Ala Val
115 120 125
His His Gly Arg Ala Ala Ala Ile Thr Met Thr Gln Ala Thr Glu Ala
130 135 140
Gly Thr Val Tyr Thr Leu Asp Glu Ile Asp Ala Ile Ser Lys Ile Ala
145 150 155 160
Lys Glu Asn Gly Leu Pro Leu His Met Asp Gly Ala Arg Phe Ala Asn
165 170 175
Ala Leu Ala Ala Leu Gly Thr Thr Pro Ala Glu Met Thr Trp Lys Arg
180 185 190
Gly Val Asp Val Leu Ser Phe Gly Gly Thr Lys Asn Gly Cys Trp Cys
195 200 205
Ala Glu Ala Ile Val Phe Phe Asp Pro Ser Leu Ala Arg Asp Phe Ser
210 215 220
Phe Leu Arg Lys Arg Thr Ala Gln Leu Phe Ser Lys Ser Arg Phe Ile
225 230 235 240
Ala Ala Gln Phe Glu Ala Tyr Leu Gln Asp Asp Leu Trp Leu Gly Leu
245 250 255
Ala Gly His Ala Asn Ala Met Ala Asn Arg Leu Arg Ala Gly Phe Gly
260 265 270
Ser Leu Asn Ser Ala Arg Leu Ala Trp Pro Thr Gln Ala Asn Glu Val
275 280 285
Phe Ala Ile Leu Pro Lys Ala Ala Ala Glu Ala Ala Thr Gln Lys Gly
290 295 300
Ala Lys Phe Tyr Asp Trp Leu Glu Pro Arg Asp Met Pro Glu Asn Val
305 310 315 320
Gly Lys Asp Glu Val Leu Ile Arg Met Val Thr Ser Phe Ala Thr Thr
325 330 335
Glu Ala Asp Val Asp Glu Phe Leu Ser Ile Cys Ala Ala Val
340 345 350
<210> 3
<211> 350
<212> PRT
<213> Agrobacterium
<400> 3
Met Phe Phe Ala Ser Asp Asn Trp Ala Gly Ala His Pro Ala Val Asn
1 5 10 15
Glu Arg Leu Ser Arg Glu Ser Thr Arg Phe Ala Ala Ala Tyr Gly Thr
20 25 30
Ser Glu Leu Asp Leu Ser Ile Glu Lys Arg Phe Asn Glu Ile Phe Glu
35 40 45
Arg Glu Val Ala Val Phe Phe Val Ala Thr Gly Thr Ala Ala Asn Ser
50 55 60
Leu Ser Leu Ala Ser Ile Ala Arg Pro Gly Gly Leu Thr Phe Cys His
65 70 75 80
Ser Glu Ala His Val Ile Glu Asp Glu Cys Gly Ala Pro Asp Phe Phe
85 90 95
Ser Gly Met Arg Met Val Ala Val Glu Gly Pro Asp Gly Lys Met Leu
100 105 110
Pro Glu Asn Leu Ile Glu Arg Ile Ala Arg Tyr Pro Gln Asp Ala Val
115 120 125
His His Gly Arg Ala Ala Ala Ile Thr Met Thr Gln Ala Thr Glu Ala
130 135 140
Gly Thr Val Tyr Thr Leu Asp Glu Ile Asp Ala Ile Ser Lys Ile Ala
145 150 155 160
Lys Glu Asn Gly Leu Pro Leu His Met Asp Gly Ala Arg Phe Ala Asn
165 170 175
Ala Leu Ala Ala Leu Gly Thr Thr Pro Ala Glu Met Thr Trp Lys Arg
180 185 190
Gly Val Asp Val Leu Ser Phe Gly Gly Ser Lys Asn Gly Cys Trp Cys
195 200 205
Ala Glu Ala Ile Val Phe Phe Asp Pro Ser Leu Ala Arg Asp Phe Ser
210 215 220
Phe Leu Arg Lys Arg Thr Ala Gln Leu Phe Ser Lys Ser Arg Phe Ile
225 230 235 240
Ala Ala Gln Phe Glu Ala Tyr Leu Gln Asp Asp Leu Trp Leu Gly Leu
245 250 255
Ala Gly His Ala Asn Ala Met Ala Asn Arg Leu Arg Ala Gly Phe Gly
260 265 270
Ser Leu Asn Ser Ala Arg Leu Ala Trp Pro Thr Gln Ala Asn Glu Val
275 280 285
Phe Ala Ile Leu Pro Lys Ala Ala Ala Glu Ala Ala Thr Gln Lys Gly
290 295 300
Ala Lys Phe Tyr Asp Trp Leu Glu Pro Arg Asp Met Pro Glu Asn Val
305 310 315 320
Gly Lys Asp Glu Val Leu Ile Arg Met Val Thr Ser Phe Ala Thr Thr
325 330 335
Glu Ala Asp Val Asp Glu Phe Leu Ser Ile Cys Ala Ala Val
340 345 350
<210> 4
<211> 350
<212> PRT
<213> Agrobacterium
<400> 4
Met Phe Phe Ala Ser Asp Asn Trp Ala Gly Ala His Pro Ala Val Asn
1 5 10 15
Glu Arg Leu Ser Arg Glu Ser Thr Arg Phe Ala Ala Ala Tyr Gly Thr
20 25 30
Ser Glu Leu Asp Leu Ser Ile Glu Lys Arg Phe Asn Glu Ile Phe Glu
35 40 45
Arg Glu Val Ala Val Phe Phe Val Ala Thr Gly Thr Ala Ala Asn Ser
50 55 60
Leu Ser Leu Ala Ser Ile Ala Arg Pro Gly Gly Leu Thr Phe Cys His
65 70 75 80
Ser Glu Ala His Val Ile Glu Asp Glu Cys Gly Ala Pro Asp Phe Phe
85 90 95
Ser Gly Met Arg Met Val Ala Val Glu Gly Pro Asp Gly Lys Met Leu
100 105 110
Pro Glu Asn Leu Ile Glu Arg Ile Ala Arg Tyr Pro Gln Asp Ala Val
115 120 125
His His Gly Arg Ala Ala Ala Ile Thr Met Thr Gln Ala Thr Glu Ala
130 135 140
Gly Thr Val Tyr Thr Leu Asp Glu Ile Asp Ala Ile Ser Lys Ile Ala
145 150 155 160
Lys Glu Asn Gly Leu Pro Leu His Met Asp Gly Ala Arg Phe Ala Asn
165 170 175
Ala Leu Ala Ala Leu Gly Thr Thr Pro Ala Glu Met Thr Trp Lys Arg
180 185 190
Gly Val Asp Val Leu Ser Phe Gly Gly Gly Lys Asn Gly Cys Trp Cys
195 200 205
Ala Glu Ala Ile Val Phe Phe Asp Pro Ser Leu Ala Arg Asp Phe Ser
210 215 220
Phe Leu Arg Lys Arg Thr Ala Gln Leu Phe Ser Lys Ser Arg Phe Ile
225 230 235 240
Ala Ala Gln Phe Glu Ala Tyr Leu Gln Asp Asp Leu Trp Leu Gly Leu
245 250 255
Ala Gly His Ala Asn Ala Met Ala Asn Arg Leu Arg Ala Gly Phe Gly
260 265 270
Ser Leu Asn Ser Ala Arg Leu Ala Trp Pro Thr Gln Ala Asn Glu Val
275 280 285
Phe Ala Ile Leu Pro Lys Ala Ala Ala Glu Ala Ala Thr Gln Lys Gly
290 295 300
Ala Lys Phe Tyr Asp Trp Leu Glu Pro Arg Asp Met Pro Glu Asn Val
305 310 315 320
Gly Lys Asp Glu Val Leu Ile Arg Met Val Thr Ser Phe Ala Thr Thr
325 330 335
Glu Ala Asp Val Asp Glu Phe Leu Ser Ile Cys Ala Ala Val
340 345 350
<210> 5
<211> 29
<212> DNA
<213> 人工序列
<400> 5
tgtctttcgg cggctcgaaa aacggctgc 29
<210> 6
<211> 29
<212> DNA
<213> 人工序列
<400> 6
gcagccgttt ttcgagccgc cgaaagaca 29
<210> 7
<211> 32
<212> DNA
<213> 人工序列
<400> 7
ctgtctttcg gcggcgggaa aaacggctgc tg 32
<210> 8
<211> 32
<212> DNA
<213> 人工序列
<400> 8
cagcagccgt ttttcccgcc gccgaaagac ag 32
Claims (10)
1.一种L-苏氨酸醛缩酶突变体,其特征在于,所述L-苏氨酸醛缩酶突变体包括:以SEQID No.2所示野生型的L-苏氨酸醛缩酶为模板,第202位苏氨酸替换为丝氨酸所形成的L-苏氨酸醛缩酶突变体T202S,其氨基酸序列如SEQ ID No.3所示;以及以SEQ ID No.2所示野生型的L-苏氨酸醛缩酶为模板,第202位苏氨酸替换为甘氨酸所形成的L-苏氨酸醛缩酶突变体T202G,其氨基酸序列如SEQ ID No.4所示。
2.一种编码如权利要求1所述的L-苏氨酸醛缩酶突变体的编码基因。
3.一种包含如权利要求2所述的L-苏氨酸醛缩酶突变体的编码基因的重组表达载体。
4.一种包含如权利要求2所述的L-苏氨酸醛缩酶突变体的编码基因的重组表达转化体。
5.一种L-苏氨酸醛缩酶突变体催化剂,其特征在于,所述L-苏氨酸醛缩酶突变体催化剂是以下形式中的任意一种:
1)培养如权利要求4所述的重组表达转化体,分离含有所述L-苏氨酸醛缩酶突变体的转化体细胞;
2)培养如权利要求4所述的重组表达转化体,分离含有所述L-苏氨酸醛缩酶突变体的粗酶液;
3)培养如权利要求4所述的重组表达转化体,分离含有所述L-苏氨酸醛缩酶突变体的粗酶液,干燥所制备的粗酶粉或纯化所制备的纯酶;
4)培养如权利要求4所述的重组表达转化体,分离含有所述L-苏氨酸醛缩酶突变体的转化体细胞,之后冷冻干燥得到的冻干菌粉。
6.一种利用如权利要求1所述的L-苏氨酸醛缩酶突变体或如权利要求5所述的L-苏氨酸醛缩酶突变体催化剂在催化甲醛和甘氨酸生成L-丝氨酸中的应用。
7.根据权利要求6所述的应用,其特征在于,使用权利要求1所述L-苏氨酸醛缩酶突变体或权利要求5所述L-苏氨酸醛缩酶突变体催化剂,催化甲醛和甘氨酸的羟醛缩合反应,获得L-丝氨酸。
8.根据权利要求7所述的应用,其特征在于,所述L-苏氨酸醛缩酶突变体催化甲醛和甘氨酸的羟醛缩合反应在辅酶磷酸吡哆醛的存在下进行。
9.根据权利要求8所述的应用,其特征在于,底物甲醛的浓度为10~300mM,底物甘氨酸的浓度为100~1500mM,所述L-苏氨酸醛缩酶突变体的用量为冻干菌粉5~30g/L,辅酶磷酸吡哆醛的添加量为10~200μM。
10.根据权利要求9所述的应用,其特征在于,所述羟醛缩合反应在pH 6~10,20~50℃的条件下进行,反应时间小于24h。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210550936.6A CN115109769B (zh) | 2022-05-20 | 2022-05-20 | 一种l-苏氨酸醛缩酶突变体以及在l-丝氨酸合成中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210550936.6A CN115109769B (zh) | 2022-05-20 | 2022-05-20 | 一种l-苏氨酸醛缩酶突变体以及在l-丝氨酸合成中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115109769A CN115109769A (zh) | 2022-09-27 |
CN115109769B true CN115109769B (zh) | 2023-07-14 |
Family
ID=83326318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210550936.6A Active CN115109769B (zh) | 2022-05-20 | 2022-05-20 | 一种l-苏氨酸醛缩酶突变体以及在l-丝氨酸合成中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115109769B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115747194B (zh) * | 2022-10-28 | 2023-11-14 | 浙江大学 | 一种L-苏氨酸醛缩酶突变体、基因及制备L-anti-对甲砜基苯丝氨酸的方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005047472A2 (en) * | 2003-11-10 | 2005-05-26 | Boyce Thompson Institute For Plant Research | Increasing seed threonine content through alteration of threonine aldolase activity |
CN111394343A (zh) * | 2020-04-22 | 2020-07-10 | 重庆大学 | L-苏氨酸醛缩酶突变体r318l及其应用 |
WO2021080277A1 (ko) * | 2019-10-23 | 2021-04-29 | 한국생명공학연구원 | 신규 d-트레오닌 생산 효소 및 이를 이용한 d-트레오닌의 입체특이적 생산 방법 |
CN113481188A (zh) * | 2018-11-06 | 2021-10-08 | 王喆明 | 苏氨酸醛缩酶的突变体及其在制备取代苯丝氨酸衍生物中的应用 |
-
2022
- 2022-05-20 CN CN202210550936.6A patent/CN115109769B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005047472A2 (en) * | 2003-11-10 | 2005-05-26 | Boyce Thompson Institute For Plant Research | Increasing seed threonine content through alteration of threonine aldolase activity |
CN113481188A (zh) * | 2018-11-06 | 2021-10-08 | 王喆明 | 苏氨酸醛缩酶的突变体及其在制备取代苯丝氨酸衍生物中的应用 |
WO2021080277A1 (ko) * | 2019-10-23 | 2021-04-29 | 한국생명공학연구원 | 신규 d-트레오닌 생산 효소 및 이를 이용한 d-트레오닌의 입체특이적 생산 방법 |
CN111394343A (zh) * | 2020-04-22 | 2020-07-10 | 重庆大学 | L-苏氨酸醛缩酶突变体r318l及其应用 |
Non-Patent Citations (2)
Title |
---|
L-苏氨酸醛缩酶催化合成L-4-硝基苯基丝氨酸;余进海;吴婷;刘均忠;张宏娟;焦庆才;;精细化工(第12期);摘要 * |
NCBI Reference Sequence: WP_006313436.1;GenBank;《GenBank》;序列 * |
Also Published As
Publication number | Publication date |
---|---|
CN115109769A (zh) | 2022-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11220701B2 (en) | Method for enzymatic preparation of R-3 aminobutyric acid | |
CN109777763B (zh) | 一株用于l-茶氨酸生产的基因工程菌及其构建与应用 | |
CN114874964B (zh) | 一种高产2′-岩藻糖基乳糖的重组大肠杆菌的构建方法及应用 | |
CN108795916B (zh) | 一种赖氨酸脱羧酶突变体、其编码基因及其表达和应用 | |
CN108467860B (zh) | 一种高产γ-氨基丁酸的方法 | |
JP6431205B2 (ja) | 新規リシンデカルボキシラーゼ、及びそれを利用してカダベリンを生産する方法 | |
CN112908417B (zh) | 功能序列和结构模拟相结合的基因挖掘方法、nadh偏好型草铵膦脱氢酶突变体及应用 | |
CN112831488A (zh) | 一种谷氨酸脱羧酶及γ-氨基丁酸高产菌株 | |
CN101985616B (zh) | 一种制备固定化腺苷甲硫氨酸合成酶和腺苷甲硫氨酸的方法 | |
CN106520715B (zh) | 一种短链脱氢酶及其基因、重组表达载体、基因工程菌及其在虾青素手性中间体合成中的应用 | |
CN115109769B (zh) | 一种l-苏氨酸醛缩酶突变体以及在l-丝氨酸合成中的应用 | |
CN108753858A (zh) | 一种l-氨基酸的生产方法 | |
CN111454918B (zh) | 一种烯醇还原酶突变体及其在制备(r)-香茅醛中的应用 | |
CN114107270A (zh) | 一种L-天冬氨酸β-脱羧酶突变体 | |
CN109402188B (zh) | 一种来自短小芽孢杆菌的ω-转氨酶及在生物胺化中的应用 | |
CN109295023B (zh) | 谷氨酸氧化酶突变体、核酸分子及应用和制备酮戊二酸的方法 | |
CN117987338A (zh) | 产麦角硫因重组谷氨酸棒杆菌及其构建方法与应用 | |
CN114350630B (zh) | L-泛解酸内酯脱氢酶、突变体及其应用 | |
CN112410353A (zh) | 一种fkbS基因、含其的基因工程菌及其制备方法和用途 | |
WO2024197480A1 (zh) | 一种利用酰胺酶合成右旋酮洛芬的方法 | |
CN103923889A (zh) | 一种苯乙醛还原酶突变体 | |
CN105969755A (zh) | 一种酪氨酸脱羧酶突变体及其基因和应用 | |
CN113528366A (zh) | 一种产beta-丙氨酸酵母菌及其构建方法 | |
US20140107377A1 (en) | Microorganisms And Methods For Producing Acrylate And Other Products From Propionyl-CoA | |
JP4729919B2 (ja) | 微生物の培養方法及び光学活性カルボン酸の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |